Effects of maternal antibodies in infants on the immunogenicity and safety of inactivated polio vaccine in infants

References

• Zhuang CL, Lin ZJ, Bi ZF, Qiu LX, Hu FF, Liu XH, Lin BZ, Su YY, Pan HR, Zhang TY, et al. Inflammation-Related adverse reactions following vaccination potentially indicate a stronger immune response. Emerg Microbes Infect. 2021;10(1):365–7. doi:10.1080/22221751.2021.1891002.
   PubMed Web of Science ®Google Scholar
• Luo HM, Zhang Y, Wang XQ, Yu WZ, Wen N, Yan DM, Wang HQ, Wushouer F, Wang HB, Xu AQ, et al. Identification and control of a poliomyelitis outbreak in Xinjiang, China. N Engl J Med. 2013;369(21):1981–90. doi:10.1056/NEJMoa1303368.
   PubMed Web of Science ®Google Scholar
• De Jesus NH. Epidemics to eradication: the modern history of poliomyelitis. Virol J. 2007;4(1):70. doi:10.1186/1743-422x-4-70.
   PubMedGoogle Scholar
• Minor P. Vaccine-Derived poliovirus (VDPV): Impact on poliomyelitis eradication. Vaccine. 2009;27(20):2649–52. doi:10.1016/j.vaccine.2009.02.071.
   PubMed Web of Science ®Google Scholar
• Aylward B, Yamada T. The polio endgame. N Engl J Med. 2011;364(24):2273–75. doi:10.1056/NEJMp1104329.
   PubMed Web of Science ®Google Scholar
• Hampton LM, Farrell M, Ramirez-Gonzalez A, Menning L, Shendale S, Lewis I, Rubin J, Garon J, Harris J, Hyde T, et al. Cessation of trivalent oral poliovirus vaccine and introduction of inactivated poliovirus vaccine — Worldwide, 2016. MMWR Morb Mortal Wkly Rep. 2016;65(35):934–38. doi:10.15585/mmwr.mm6535a3.
   PubMed Web of Science ®Google Scholar
• du Chatelet IP, Merchant AT, Fisher-Hoch S, Luby SP, Plotkin SA, Moatter T, Agboatwalla M, Mc Cormick JB. Serological response and poliovirus excretion following different combined oral and inactivated poliovirus vaccines immunization schedules. Vaccine. 2003;21(15):1710–18. doi:10.1016/s0264-410x(02)00523-6.
   PubMed Web of Science ®Google Scholar
• Leuridan E, Van Damme P. Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns. Vaccine. 2007;25(34):6296–304. doi:10.1016/j.vaccine.2007.06.020.
   PubMed Web of Science ®Google Scholar
• Caceres VM, Strebel PM, Sutter RW. Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review. Clin Infect Dis. 2000;31(1):110–19. doi:10.1086/313926.
   PubMed Web of Science ®Google Scholar
• Szenborn L, Tischer A, Pejcz J, Rudkowski Z, Wojcik M. Passive acquired immunity against measles in infants born to naturally infected and vaccinated mothers. Med Sci Monit. 2003;9:CR541–546.
   PubMedGoogle Scholar
• Moon S-S, Groome MJ, Velasquez DE, Parashar UD, Jones S, Koen A, van Niekerk N, Jiang B, Madhi SA. Prevaccination rotavirus serum IgG and IgA are Associated with lower immunogenicity of live, oral human rotavirus vaccine in South African infants. Clin Infect Dis. 2016;62(2):157–65. doi:10.1093/cid/civ828.
   PubMed Web of Science ®Google Scholar
• World Health Organization Collaborative Study Group on Oral Poliovirus Vaccine. Factors affecting the immunogenicity of oral poliovirus vaccine: a prospective evaluation in Brazil and the Gambia. J Infect Dis. 1995;171(5):1097–106. doi:10.1093/infdis/171.5.1097.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Baer M, Willems P. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years. Pediatr Infect Dis J. 2007;26(2):153–58. doi:10.1097/01.inf.0000250689.09396.21.
   PubMed Web of Science ®Google Scholar
• Hu Y, Wang J, Zeng G, Chu K, Jiang D, Zhu F, Ying Z, Chen L, Li C, Zhu F, et al. Immunogenicity and safety of a sabin strain-based inactivated polio vaccine: a Phase 3 clinical trial. J Infect Dis. 2019;220(10):1551–57. doi:10.1093/infdis/jiy736.
   PubMed Web of Science ®Google Scholar
• Herve C, Laupeze B, Del Giudice G, Didierlaurent AM, Da Silva FT. The how’s and what’s of vaccine reactogenicity. NPJ Vaccines. 2019;4(1). doi:10.1038/s41541-019-0132-6.
   PubMed Web of Science ®Google Scholar
• Glezen WP. Effect of maternal antibodies on the infant immune response. Vaccine. 2003;21(24):3389–92. doi:10.1016/s0264-410x(03)00339-6.
   PubMed Web of Science ®Google Scholar
• Lindsey B, Jones C, Kampmann B. Bridging the gap: maternal immunisation as a means to reduce neonatal deaths from infectious diseases. Pathog Glob Health. 2012;106(3):137–38. doi:10.1179/204777312x13462106637684.
   PubMed Web of Science ®Google Scholar
• Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D, Gilbert PB, Lama JR, Marmor M, Del Rio C, et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet. 2008;372(9653):1881–93. doi:10.1016/s0140-6736(08)61591-3.
   PubMed Web of Science ®Google Scholar
• Sasaki S, He X-S, Holmes TH, Dekker CL, Kemble GW, Arvin AM, Greenberg HB. Influence of prior influenza vaccination on antibody and B-cell responses. Plos One. 2008;3(8):e2975. doi:10.1371/journal.pone.0002975.
   PubMed Web of Science ®Google Scholar
• Barug D, Pronk I, van Houten MA, Versteegh FGA, Knol MJ, van de Kassteele J, Berbers GAM, Sanders EAM, Rots NY. Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial. Lancet Infect Dis. 2019;19(4):392–401. doi:10.1016/s1473-3099(18)30717-5.
   PubMed Web of Science ®Google Scholar
• Voysey M, Kelly DF, Fanshawe TR, Sadarangani M, O’-Brien KL, Perera R, Pollard AJ. The influence of maternally derived antibody and infant age at vaccination on infant vaccine responses an individual participant meta-analysis. JAMA Pediatr. 2017;171(7):637–46. doi:10.1001/jamapediatrics.2017.0638.
   PubMed Web of Science ®Google Scholar
• Dayan GH, Thorley M, Yamamura Y, Rodriguez N, McLaughlin S, Torres LM, Seda A, Carbia M, Alexander LN, Caceres V, et al. Serologic response to inactivated poliovirus vaccine: a randomized clinical trial comparing 2 vaccination schedules in Puerto Rico. J Infect Dis. 2007;195(1):12–20. doi:10.1086/508427.
   PubMed Web of Science ®Google Scholar
• Asturias EJ, Dueger EL, Omer SB, Melville A, Nates SV, Laassri M, Chumakov K, Halsey NA. Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants. J Infect Dis. 2007;196(5):692–98. doi:10.1086/520546.
   PubMed Web of Science ®Google Scholar
• Cramer JP, Jimeno J, Han HH, Lin S, Hartmann K, Borkowski A, Saez-Llorens X. Safety and immunogenicity of experimental stand-alone trivalent, inactivated Sabin-strain polio vaccine formulations in healthy infants: a randomized, observer-blind, controlled phase 1/2 trial. Vaccine. 2020;38(33):5313–23. doi:10.1016/j.vaccine.2020.05.081.
   PubMed Web of Science ®Google Scholar
• Tang R, Chu K, Hu Y, Chen L, Zhang M, Liu S, Ma H, Wang J, Zhu F, Hu Y, et al. Effect of maternal antibody on the infant immune response to inactivated poliovirus vaccines made from Sabin strains. Hum Vaccines Immunother. 2019;15(5):1160–66. doi:10.1080/21645515.2019.1572410.
   PubMed Web of Science ®Google Scholar
• Andrews NJ, Walker WT, Finn A, Heath PT, Collinson AC, Pollard AJ, Snape MD, Faust SN, Waight PA, Hoschler K, et al. Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines. Vaccine. 2011;29(45):7913–19. doi:10.1016/j.vaccine.2011.08.076.
   PubMed Web of Science ®Google Scholar
• Grabenstein JD, Manoff SB. Pneumococcal polysaccharide 23-valent vaccine: Long-term persistence of circulating antibody and immunogenicity and safety after revaccination in adults. Vaccine. 2012;30(30):4435–44. doi:10.1016/j.vaccine.2012.04.052.
   PubMed Web of Science ®Google Scholar
• Kang G, Tang F, Wang Z, Hu R, Yu J, Gao J. Surveillance of adverse events following the introduction of inactivated poliovirus vaccine made from Sabin strains (sIPV) to the Chinese EPI and a comparison with adverse events following inactivated poliovirus vaccine made from wild strains (wIPV) in Jiangsu, China. Hum Vaccines Immunother. 2021;17(8):2568–74. doi:10.1080/21645515.2021.1898306.
   PubMed Web of Science ®Google Scholar